ARTICLE | Company News
CytImmune, AstraZeneca deal
January 7, 2013 8:00 AM UTC
AstraZeneca partnered with CytImmune to evaluate the feasibility of combining an undisclosed preclinical cancer compound from the pharma with CytImmune's CYT-6091. CytImmune said the companies plan t...